Ameli Trope
Overview
Explore the profile of Ameli Trope including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bjorge T, Stoer N, Hverven S, Nygard M, Trope A, Engesaeter B
Int J Cancer
. 2025 Feb;
PMID: 39921417
As many countries are transitioning from cytology to human papillomavirus (HPV) testing as the primary cervical cancer screening test, we evaluated the impact of cumulative HPV screening during the implementation...
2.
Knudsen A, Randrup T, Kesmodel U, Booth B, Gustafson L, Trope A, et al.
BMJ Open
. 2024 Dec;
14(12):e085382.
PMID: 39675832
Introduction: Colposcopy is a standard procedure for evaluating cervical abnormalities and collecting cervical biopsies. The procedure is associated with intra- and inter-observer variation. A colposcopic scoring system, Swedescore, has been...
3.
Partanen V, Dillner J, Trope A, Agustsson A, Lonnberg S, Heinavaara S, et al.
Eur J Public Health
. 2024 Jan;
34(2):354-360.
PMID: 38261374
Background: Cervical cytology has been the primary method of cervical cancer screening for decades. Tests that detect viral HPV are shown in several randomized trials to provide better protection against...
4.
Portnoy A, Pedersen K, Sy S, Trope A, Engesaeter B, Kim J, et al.
Int J Cancer
. 2023 Dec;
154(6):1073-1081.
PMID: 38088449
As Norway considers revising triage approaches following their first adolescent cohort with human papillomavirus (HPV) vaccination entering the cervical cancer screening program, we analyzed the health impact and cost-effectiveness of...
5.
Gjerde P, Tollanes M, Trope A, Eide M, Natvik M, Puntervoll H
Tidsskr Nor Laegeforen
. 2023 Aug;
143(11).
PMID: 37589352
Background: In Norway, approximately 360 000 cervical screening samples were taken in 2020, of which 11 000 were registered as inadequate. We therefore wished to investigate doctors' knowledge of cervical...
6.
Orumaa M, Campbell S, Stoer N, Castle P, Sen S, Trope A, et al.
JMIR Serious Games
. 2022 Dec;
10(4):e36197.
PMID: 36512401
Background: The wide availability of mobile phones has made it easy to disseminate health-related information and make it accessible. With gamification, mobile apps can nudge people to make informed health...
7.
Aasbo G, Trope A, Nygard M, Christiansen I, Baasland I, Iversen G, et al.
Br J Cancer
. 2022 Aug;
127(10):1816-1826.
PMID: 35995936
Background: Cervical cancer screening participation is suboptimal in most settings. We assessed whether human papillomavirus (HPV) self-sampling may increase screening participation among long-term non-attenders in Norway. Methods: A pragmatic randomised...
8.
Nygard M, Engesaeter B, Castle P, Berland J, Eide M, Iversen O, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Jul;
31(9):1812-1822.
PMID: 35793700
Background: Cervical cancer screening programs are facing a programmatic shift where screening protocol based on human papillomavirus testing (HPV-Screening protocol) is replacing the liquid-based cytology (LBC-Screening protocol). For safe technology...
9.
Pedersen K, Portnoy A, Sy S, Hansen B, Trope A, Kim J, et al.
Int J Cancer
. 2021 Oct;
150(3):491-501.
PMID: 34664271
Several countries have implemented primary human papillomavirus (HPV) testing for cervical cancer screening. HPV testing enables home-based, self-collected sampling (self-sampling), which provides similar diagnostic accuracy as clinician-collected samples. We evaluated...
10.
Brevik T, Trope A, Laake P, Bjorkly S
Med Care
. 2021 Jun;
59(10):893-900.
PMID: 34108408
Background: Many ethnic minority women have low attendance at breast cancer screening. Objectives: This brief report explores whether women's screening histories impact mammography screening attendance after tailored education. Research Design:...